234 results on '"Disertori, Marcello"'
Search Results
2. Total NT-proBNP, a novel biomarker related to recurrent atrial fibrillation
3. Ventricular tachycardia-inducibility predicts arrhythmic events in post-myocardial infarction patients with low ejection fraction. A systematic review and meta-analysis
4. Myocardial fibrosis predicts ventricular tachyarrhythmias
5. How To Choose Between Single-Chamber and Dual-Chamber ICD
6. Cardiac Remodeling, Circulating Biomarkers and Clinical Events in Patients with a History of Atrial Fibrillation. Data from the GISSI-AF Trial
7. The AV synchrogram: A novel approach to quantify atrioventricular coupling during atrial arrhythmias
8. The post‐DANISH era in clinical cardiology: Need of a better selection of patients for implantable cardioverter‐defibrillator in dilated cardiomyopathy
9. Clinical characteristics of patients with asymptomatic recurrences of atrial fibrillation in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico–Atrial Fibrillation (GISSI-AF) trial
10. Clinical predictors of atrial fibrillation recurrence in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico–Atrial Fibrillation (GISSI-AF) trial
11. Additional file 1 of Total NT-proBNP, a novel biomarker related to recurrent atrial fibrillation
12. Systematic Review and Meta-Analysis: Renin-Angiotensin System Inhibitors in the Prevention of Atrial Fibrillation Recurrences. An Unfulfilled Hope
13. Myocardial infarction due to late stent thrombosis following epileptic convulsive seizures
14. Electroanatomic Mapping and Late Gadolinium Enhancement MRI in a Genetic Model of Arrhythmogenic Atrial Cardiomyopathy
15. The paradox of implantable cardioverter-defibrillator: When guidelines may play against care improvement
16. The need to modify patient selection to improve the benefits of implantable cardioverter-defibrillator for primary prevention of sudden death in non-ischaemic dilated cardiomyopathy
17. Dual Defibrillator Improves Quality of Life and Decreases Hospitalizations in Patients with Drug Refractory Atrial Fibrillation
18. Evidence of unbalanced regulatory mechanism of heart rate and systolic pressure after acute myocardial infarction
19. Acute Atrial Dilatation Slows Conduction and Increases AF Vulnerability in the Human Atrium
20. Is the clinical benefit of primary prevention implantable cardioverter-defibrillator overestimated? The role of sudden cardiac death to total mortality ratio
21. Author’s reply: “Declining clinical benefit of ICD in heart failure patients”
22. Declining clinical benefit of ICD in heart failure patients: Temporal trend of mortality outcomes from randomized controlled trials
23. Predicting atrial fibrillation recurrence with circulating inflammatory markers in patients in sinus rhythm at high risk for atrial fibrillation: data from the GISSI atrial fibrillation trial
24. Atrial fibrillation ablation procedure using electroanatomic reconstruction of the right and left atrium in a patient affected by dextrocardia
25. Valsartan and Recurrent Atrial Fibrillation
26. Deterioration of Organization in the First Minutes of Atrial Fibrillation: A Beat-to-Beat Analysis of Cycle Length and Wave Similarity
27. Standardized-care pathway vs. usual management of syncope patients presenting as emergencies at general hospitals
28. Three-dimensional reconstruction of right lung circulation in a patient with isolated absence of right pulmonary artery
29. Enormous bi-atrial enlargement in a persistent idiopathic atrial standstill
30. Incidence of atrial fibrillation in a population with impaired glucose tolerance: The contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial
31. Evidence of low- and high-frequency oscillations in human AV interval variability: evaluation with spectral analysis
32. Heart failure patients unresponsive to implantable cardioverter‐defibrillator therapy: a neglected problem
33. Implantable Cardioverter-Defibrillator in Dilated Cardiomyopathy after the DANISH-Trial Lesson. A Poly-Parametric Risk Evaluation Is Needed to Improve the Selection of Patients
34. Characterization of rate and regularity of ventricular response during atrial tachyarrhythmias. Insight on atrial and nodal determinants
35. Primary Prevention of Sudden Arrhythmic Death in Dilated Cardiomyopathy
36. Heart Rate Turbulence Is a Powerful Predictor of Cardiac Death and Ventricular Arrhythmias in Postmyocardial Infarction and Heart Failure Patients
37. Considerazioni su una valutazione poliparametrica nella stratificazione del rischio di morte improvvisa per l'indicazione all'impianto di cardioverter-defibrillatore in prevenzione primaria, nella disfunzione ventricolare sinistra di origine ischemica e non ischemica. Position paper dell'Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO)
38. Causal linear parametric model for baroreflex gain assessment in patients with recent myocardial infarction
39. Myocardial Fibrosis Assessment by LGE Is a Powerful Predictor of Ventricular Tachyarrhythmias in Ischemic and Nonischemic LV Dysfunction
40. Improving the appropriateness of sudden arrhythmic death primary prevention by implantable cardioverter-defibrillator therapy in patients with low left ventricular ejection fraction. Point of view
41. Atrial fibrillation and NPPA gene p.S64R mutation
42. Diabetes mellitus as risk factor for atrial fibrillation hospitalization: Incidence and outcomes over nine years in a region of Northern Italy
43. Atrial fibrillation requiring urgent medical care. Approach and outcome in the various departments of admission. Data from the atrial Fibrillation/flutter Italian REgistry (FIRE)
44. The logical operator map identifies novel candidate markers for critical sites in patients with atrial fibrillation
45. Coronary artery narrowing after aortic root reconstruction with resorcin-formalin glue
46. Autosomal recessive paediatric sick sinus syndrome associated with novel compound mutations in SCN5A
47. Thromboembolic event rate in paroxysmal and persistent atrial fibrillation: Data from the GISSI-AF trial
48. Autosomal Recessive Atrial Dilated Cardiomyopathy With Standstill Evolution Associated With Mutation of Natriuretic Peptide Precursor A
49. Anatomic Localization of Rapid Repetitive Sources in Persistent Atrial Fibrillation
50. Nodal recovery, dual pathway physiology, and concealed conduction determine complex AV dynamics in human atrial tachyarrhythmias
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.